2021
DOI: 10.2460/javma.259.5.494
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of neutrophilia as a prognostic factor in dogs with multicentric lymphoma treated with a cyclophosphamide, doxorubicin, vincristine, and prednisone–based chemotherapy protocol

Abstract: To determine whether, in dogs with naïve multicentric lymphoma, neutrophilia at the time of initial diagnosis was associated with progression-free survival time (PFST) or overall response rate (ie, percentage of dogs with a complete or partial remission) and whether the initial neutrophil-to-lymphocyte ratio was associated with PFST. ANIMALS 30 dogs with multicentric lymphoma and neutrophilia (including 16 treated with a cyclophosphamide, doxorubicin, vincristine, and prednisone [CHOP]-based protocol) and 37 h… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 45 publications
0
2
0
Order By: Relevance
“…There were an additional 26 papers including 33 groups and 1606 cases [11,32,35,36,52,57,62,78,82,84,86,87,95,96,101,[104][105][106]119,128,129,133,136,151,161,171] treated with a CHOP-like protocol where the location or distribution of the lymphoma were not clearly defined. Two papers included only B-cell lymphoma [84,161] with the remainder either not specifying the immunotype or including a mixture.…”
Section: Remission Times Survival Times and Response Rates For Multic...mentioning
confidence: 99%
See 1 more Smart Citation
“…There were an additional 26 papers including 33 groups and 1606 cases [11,32,35,36,52,57,62,78,82,84,86,87,95,96,101,[104][105][106]119,128,129,133,136,151,161,171] treated with a CHOP-like protocol where the location or distribution of the lymphoma were not clearly defined. Two papers included only B-cell lymphoma [84,161] with the remainder either not specifying the immunotype or including a mixture.…”
Section: Remission Times Survival Times and Response Rates For Multic...mentioning
confidence: 99%
“…It is likely that most of the cases in these papers were multicentric or nodal. One paper reported only survival time [78], four only remission duration [32,86,133,136], and one reported only remission rates [82], with the remainder reporting both remission and survival durations. The outcomes are listed in Table 3.…”
Section: Remission Times Survival Times and Response Rates For Multic...mentioning
confidence: 99%